Search

Search Constraints

You searched for: Author/Creator Anderson, Kenneth C

Search Results

2. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial. Issue 10 (October 2020)

3. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group. Issue 2 (February 2022)

5. Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b–2 dose-escalation study. Issue 12 (December 2015)

7. Future cancer research priorities in the USA: a Lancet Oncology Commission. Issue 11 (November 2017)

8. Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1/2a study. Issue 11 (November 2021)

9. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Issue 8 (August 2016)

10. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders. Issue 6 (June 2019)